
Gene Therapy for Neurometabolic Diseases Lab at @INC_UAB
Joined June 2024
- Tweets15
- Following57
- Followers8
- Likes8
Bosch Lab retweeted
2/ 🤝 The development of this treatment is carried out at @INC_UAB together with @JLLanciego
(FIMA/@CIMA_unav), Miguel Chillon (@VHIR_), @lab_davidson (@CHOP_Research), Sandra Balagué (Fundación Gen Rebelde GNB1) and Christina Marouda (Alliance MLC).
Bosch Lab retweeted
1/ 🧠 Rare childhood brain disorders lack effective treatments.
Supported by the Health Research call, A. Bosch explores precision gene therapies that deliver targeted biological instructions to brain cells avoiding side effects in severe paediatric encephalopathies. 👇
tinyurl.com/466x2tke
Bosch Lab retweeted
Un projecte de recerca liderat per la Dra. Assumpció Bosch (@ABoschLab) seleccionat per la convocatòria d’Investigació en Salut 2026 de la @FundlaCaixaCAT L’equip rebrà 1.000.000 € per buscar noves teràpies gèniques per tractar trastorns cerebrals infantils.
Bosch Lab retweeted
A big congratulations to Dr. Assumpció Bosch for the selection of a project she coordinates in the CaixaResearch Health Call 2026 by @FundlaCaixa!
Just out: a comprehensive review of gene therapies in ALS – covering neuroprotection, ASOs, RNAi, CRISPR etc.; includes tables summarizing preclinical & clinical data, discusses hurdles & latest trial outcomes.
🔗Read more: liebertpub.com/doi/full/10.1…
Bosch Lab retweeted
A recent study led by Dr Assumpció Bosch (@absochlab) shows the potential of gene therapy to restore motor capacity in an ultra-rare disease (MLC), even when treatment begins after symptom onset #articledeldia
Read the article: cutt.ly/VraHlhU2
🧵👇
🔬🧬 Our latest paper has just been published in Molecular Therapy (@MolTherapy)! In this study, conducted at @INC_UAB @UABBarcelona , we developed an intravenous gene therapy for MLC, an ultrarare leukodystrophy.
cell.com/molecular-therapy-f…
Our PI participated in the 9th Annual Wolfram Syndrome Research Symposium where she gave a talk on our latest findings. Thank you to the Snow Foundation for organizing this impactful event. We appreciate the opportunity to engage with the community!
🔗 shorturl.at/yci0p
75
Last week at #ESGCT2024 was incredible! Our team, alongside the Gene Therapy for CNS lab, showcased our work with 3 posters on gene therapies for rare diseases: MLC, SPG52, and ALS. It's always exciting to contribute to the future of the field and connect with colleagues!
PhD student Rubén Guerrero Yagüe presented his poster at the ESACT 2024 conference in Edinburgh on the 24th of June. He showcased the results from his thesis project conducted in our lab and discussed the future steps needed to advance the research! #ESACT2024 #PhD #Research
3
90
We are excited to share that our group is taking part in this groundbreaking project!
La 'spin-off' de la UAB Anew Medical empieza a cotizar en el Nasdaq
La compañía, con sede en Boston, quiere levantar 20 millones para financiar una terapia contra el Alzheimer y la ELA
lavanguardia.com/dinero/2024…
lavanguardia.com/dinero/2024…
3
100
Bosch Lab retweeted
📰 La spin-off de la @UABBarcelona, ANEW MEDICAL, ja cotitza al @Nasdaq!
Aquesta fita permetrà avançar en les teràpies gèniques per a malalties com l’#Alzheimer i l’esclerosi lateral amiotròfica (#ELA), patentades per la #UAB i @icreacommunity.
🔗 tuit.cat/daaok
Assumpció Bosch presented the MLC results at @UlfUnited Family Conference this weekend. She showed the in-vivo results performed in our lab and highlighted the next steps needed to bring the therapy to the clinic!
2
124



























